“lorcaserin” Archives

in
Entry Author Date Location
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks 02/13/20 National
Arena’s Comeback Continues with $800M Deal for Lung Disease Drug 11/15/18 San Diego
Pernix-Backed Biz Picks Up Orexigen’s Weight Loss Drug for $74M 07/30/18 San Diego
Moving Beyond Obesity, Vivus Strikes $135M Deal for Digestive Drug 05/01/18 San Francisco
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
Arena Pharma’s Revamp Gains Traction With New Data For GI Drug 03/20/18 San Diego
Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale 03/12/18 San Diego
West Coast Biotech Roundup: Arena, Frazier, Kura, and Theranos 10/30/15 San Diego
Arena Pharmaceuticals’ Board Asks CEO Jack Lief to Retire 10/05/15 San Diego
Gelesis, PureTech’s Weight-Loss Hopeful, Postpones IPO 05/13/15 Boston
San Diego Life Sciences Roundup: Zogenix, Arena, Sorrento, and More 03/31/14 San Diego
Arena’s Expanded Marketing Deal with Eisai Has Broad Implications 11/12/13 San Diego
San Diego Life Sciences Roundup: Receptos, Arena, NuVasive, & More 05/09/13 San Diego
San Diego Life Sciences Roundup: Deals at MEI Pharma, Auspex, Ambit 11/09/12 San Diego
San Diego Life Sciences Roundup: Halozyme, Sophiris, Arena, & More 07/12/12 San Diego
SD Life Sciences Roundup: Arena, PatientSafe, MEI Pharma, & More 06/28/12 San Diego
Arena Shares Boom on FDA Approval of Obesity Drug 06/27/12 San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News 08/04/11 San Diego
Arena Passes Small Study, in Bid to Answer FDA Questions About Obesity Drug 08/02/11 San Diego
A San Diego Sampler from the War on Diabetes 06/24/11 San Diego
FDA Rejects Orexigen’s Weight-Loss Drug, Arena Lays Off 66, ResMed CEO Jumps to CareFusion, & More San Diego Life Sciences News 02/03/11 San Diego
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug 01/27/11 San Diego
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients 11/09/10 San Diego
Arena Obesity Drug Fails to Win FDA Approval, May Need More Clinical Testing 10/25/10 San Diego
FDA Panel Votes Against Arena’s Weight-Loss Drug, ImThera Encouraged by Early Test Results, Novartis Wins FDA Approval for MS Pill, & More San Diego Life Sciences News 09/23/10 San Diego
Lorcaserin Weight-Loss Trials Weigh Heavily on Arena, Ramius Raises Offer to Buy Cypress Bio, Santarus Adds to Its Drug Portfolio, & More San Diego Life Sciences News 09/16/10 San Diego
Arena Obesity Drug Was Effective by ‘Slim Margin,’ FDA Staff Raises Rat Cancer Concern; Shares Tumble 09/14/10 San Diego
Lessons Learned About the Outlook for New Obesity Drug Approval 07/16/10 National
Arena Signs Deal With Eisai for Lorcaserin, Qualcomm CEO Identifies Two Opportunities in Mobile Health, & More San Diego Life Sciences News 07/08/10 San Diego
Page 1 of 2 next page »